OneKC logo
Contact Us

Newsroom

Your source for the latest news, insights and innovation updates shaping the animal health industry.

Featured News

Subscribe to The Connector

Get the latest animal health news in our monthly newsletter.

The Connector | October 2026

Your monthly source for Animal Health industry news.
Read more

IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence

IDEXX Laboratories, Inc. announced the acquisition of CoVetAI Inc. (CoVet), a leading and rapidly growing provider of AI-native ambient listening and clinical workflow software for veterinary practices.
Read more

BiomEdit’s First-of-its-Kind Engineered Bacterial Biologic for Poultry Receives Conditional Licensure From USDA

BiomEdit announced that the U.S. Department of Agriculture's Center for Veterinary Biologics (USDA CVB) has granted conditional licensure for its lead candidate, Clostridium Perfringens Alpha Toxin and NetB Antibody Fragment, Live Limosilactobacillus Vector (CPerf LLV), previously referred to as BE-101, based on the demonstration of a reasonable expectation of efficacy in terms of reduced necrotic enteritis (NE)-associated mortality in broiler chickens challenged with Clostridium perfringens.
Read more

Big Idea Ventures and Mars Petcare Select Three Startups for the 2026 Next Generation Pet Food Program

Big Idea Ventures and Mars Petcare, together with partners AAK, Bühler, Givaudan and Ingredion, have selected three startups for the 2026 Next Generation Pet Food Program.
Read more

Dechra Brings Laverdia® (Verdinexor Tablets), the First and Only FDA-Approved Oral Treatment for Dogs Diagnosed With Lymphoma

Dechra announced the availability of Laverdia® (verdinexor tablets), the first and only FDA-approved oral treatment for dogs diagnosed with lymphoma.1
Read more

Merck Animal Health Highlights Landmark Clinical Research on Gilvetmab, the First Caninized Immune Checkpoint Inhibitor for Canine Oncology in the Journal of Veterinary Internal Medicine and Journal of the American Veterinary Medical Association

Merck Animal Health announced the publication of two peer-reviewed studies evaluating the safety and efficacy of gilvetmab, a first-in-class caninized anti–programmed cell death protein 1 (anti–PD-1) monoclonal antibody, in dogs with spontaneous malignancies.
Read more

Explore Further

Explore these resources to learn more about the Animal Health Corridor and industry.

Industry Trends & Insights

Stay informed on the market forces and innovations transforming animal health.

Market Update
Vet Clinic Trends

Corridor Asset Overview

Take a deep dive into the comprehensive benefits and assets of the KC Animal Health Corridor.

Industry Overview
KC Area Development Council
KC SmartPort
KC Animal Health Corridor
TeamKC
KC Global Design
KC Area Development Council
KC SmartPort
KC Animal Health Corridor
TeamKC
KC Global Design

Site Selection

Why KC
Find Real Estate
Taxes + Incentives
Workforce
Key Industries + Operations
Foreign Trade Zone

Lifestyle

Life in KC
Live
Careers
Entertainment
People of KC
KC Options Magazine

Events

Calendar
Programming
KCADC Annual Meeting
Industrial
Animal Health
Talent
A/E/C

Data & Resources

Research Data
Greater KC Profile
Major Employers
Maps
Communities

Newsroom

All News
Ratings & Rankings
Recent Successes
Press Kit

About KCADC

What We Do
Get Involved
Investor Listing
Contact KCADC
Why KC
Find Real Estate
Taxes + Incentives
Workforce
Key Industries + Operations
Foreign Trade Zone
Research Data
Greater KC Profile
Major Employers
Maps
Communities
Life in KC
Live
Careers
Entertainment
People of KC
KC Options Magazine
All News
Ratings & Rankings
Recent Successes
Press Kit
Calendar
Programming
KCADC Annual Meeting
Industrial
Talent
Animal Health
What We Do
Get Involved
Investor Listing
Contact KCADC
Privacy Policy | Terms of Use | Accessibility Statement
OneKC logo

© 2026 KCADC. All rights reserved.